This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Dalia Seger: Innovator in Human Signal Transduction
Introduction
Dalia Seger is a prominent inventor based in Yavne, Israel. She has made significant contributions to the field of molecular biology, particularly in the area of human signal transduction. Her work has implications for understanding various cellular processes and diseases.
Latest Patents
Dalia Seger holds 1 patent related to her research. The patent is titled "Human signal transduction MAPK kinase." It describes an isolated nucleic acid molecule that hybridizes under stringent conditions with specific nucleic acids, encoding the mitogen-activated protein kinase kinase protein. This innovation is crucial for advancing the understanding of cellular signaling pathways.
Career Highlights
Dalia Seger is affiliated with the University of Washington, where she continues her research and development in the field of signal transduction. Her academic background and expertise have positioned her as a key figure in her area of study.
Collaborations
Throughout her career, Dalia has collaborated with notable scientists, including Rony Seger and Natalie G. Ahn. These collaborations have enriched her research and contributed to the advancement of knowledge in molecular biology.
Conclusion
Dalia Seger is a distinguished inventor whose work in human signal transduction has the potential to impact various scientific fields. Her contributions, particularly through her patent, highlight her role as an innovator in molecular biology.